Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Human Xtensions founded and what is its primary focus?
- Human Xtensions was founded in January 2012. It is a medical robotics company focused on developing software-driven, hand-held devices for minimally invasive surgery.
- What significant regulatory clearance did Human Xtensions receive for its HandX product?
- In March 2018, Human Xtensions received FDA 510(k) clearance for its HandX device, a smart, electro-mechanically simplified surgical system.
- What was Human Xtensions' most recent funding round prior to its IPO?
- Human Xtensions completed a Series D funding round in January 2019, raising $9 million. Lead investor was Psagot Investment House.
- When did Human Xtensions go public and on what exchange?
- Human Xtensions went public in December 2020 via an IPO on the TASE (Tel Aviv Stock Exchange) under the ticker HUMX.
- What was the estimated valuation of Human Xtensions at the time of its IPO?
- At the time of its IPO in December 2020, Human Xtensions had an estimated valuation of $160 million.
- What was the total amount of capital raised by Human Xtensions before its IPO?
- Human Xtensions raised a total of $66 million in funding prior to its IPO.
- What is the current employee count for Human Xtensions?
- Human Xtensions currently has 42 employees.
- What operational change did Human Xtensions make regarding its US activities in April 2023?
- In April 2023, Human Xtensions reduced its operations in the US, aiming to save 31% on expenses.
- Did Human Xtensions sign any distribution agreements in 2023?
- Yes, in June 2023, Human Xtensions signed an exclusive distribution agreement in Mexico valued at approximately 20 million NIS. In October 2023, the company also entered into a distribution agreement with a company in Abu Dhabi.